Editorial Dept. Voz de la Diaspora
Panama announced that it has authorized the emergency use of the Pfizer-BioNTech vaccine to be applied from the 12 years in order to protect, and reduce infections among the younger population.
With this decision, he would expand the inoculation with Pfizer to a greater number of people, since the vaccine is applied so far to the inhabitants greater than 16 years.
“… This authorization of the vaccine against COVID-19 in adolescents from 12 a 16 years is based on safety and efficacy data in this age group as in adults ", said the Ministry of Health (MINSA) it's a statement.
The decision “does not include its use by persons under the age of 12 years", reiterated the official note.
The health authority did not specify when the immunization of young people would begin from 12 years, However, he explained that the vaccination schedule will be similar to that used with adults., that is, adolescents will receive two doses with an interval of 3 a 4 weeks.
The Panamanian immunization program against COVID-19 began last January and since then has provided around 1.7 million doses, mostly from Pfizer, which is the main supplier of vaccines in the country.
The government said that in total it expects to acquire around 9 million doses from pharmaceutical companies with the goal of immunizing more than 80% of the 4.2 millions of inhabitants, authorities say.
Panama is one of the Central American countries most affected by the coronavirus outbreak with 416,232 infections accumulated until Monday, Y 6,646 deaths, according to official reports.
On the other hand, the canal country, that registers a rise in daily infections, stands out among the nations that apply the most diagnostic tests, until the end of June he carried out 680,499 tests per million inhabitants, surpassed only by Chile, Glen, and the United States, said the government.